CRL
Price
$184.67
Change
+$9.91 (+5.67%)
Updated
Dec 3 closing price
Capitalization
9.09B
76 days until earnings call
Intraday BUY SELL Signals
CTKB
Price
$5.36
Change
-$0.03 (-0.56%)
Updated
Dec 3 closing price
Capitalization
685.36M
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRL vs CTKB

Header iconCRL vs CTKB Comparison
Open Charts CRL vs CTKBBanner chart's image
Charles River Laboratories International
Price$184.67
Change+$9.91 (+5.67%)
Volume$770.52K
Capitalization9.09B
Cytek Biosciences
Price$5.36
Change-$0.03 (-0.56%)
Volume$686.2K
Capitalization685.36M
CRL vs CTKB Comparison Chart in %
CRL
Daily Signal:
Gain/Loss:
CTKB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRL vs. CTKB commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a StrongBuy and CTKB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (CRL: $174.80 vs. CTKB: $5.41)
Brand notoriety: CRL and CTKB are both not notable
CRL represents the Medical Specialties, while CTKB is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CRL: 16% vs. CTKB: 32%
Market capitalization -- CRL: $9.09B vs. CTKB: $685.36M
CRL [@Medical Specialties] is valued at $9.09B. CTKB’s [@Medical/Nursing Services] market capitalization is $685.36M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $217.86B to $0. The average market capitalization across the [@Medical Specialties] industry is $12.57B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.77B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 1 FA rating(s) are green whileCTKB’s FA Score has 0 green FA rating(s).

  • CRL’s FA Score: 1 green, 4 red.
  • CTKB’s FA Score: 0 green, 5 red.
According to our system of comparison, CRL is a better buy in the long-term than CTKB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 4 TA indicator(s) are bullish while CTKB’s TA Score has 6 bullish TA indicator(s).

  • CRL’s TA Score: 4 bullish, 6 bearish.
  • CTKB’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, CTKB is a better buy in the short-term than CRL.

Price Growth

CRL (@Medical Specialties) experienced а -1.83% price change this week, while CTKB (@Medical/Nursing Services) price change was -7.04% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.29%. For the same industry, the average monthly price growth was +2.65%, and the average quarterly price growth was +28.81%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.78%. For the same industry, the average monthly price growth was +0.35%, and the average quarterly price growth was +7.83%.

Reported Earning Dates

CRL is expected to report earnings on Feb 18, 2026.

CTKB is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Medical Specialties (-0.29% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (-0.78% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($9.09B) has a higher market cap than CTKB($685M). CRL YTD gains are higher at: -5.309 vs. CTKB (-16.641). CRL has higher annual earnings (EBITDA): 528M vs. CTKB (-10.83M). CTKB has more cash in the bank: 262M vs. CRL (183M). CTKB has less debt than CRL: CTKB (23.7M) vs CRL (2.79B). CRL has higher revenues than CTKB: CRL (4.03B) vs CTKB (196M).
CRLCTKBCRL / CTKB
Capitalization9.09B685M1,327%
EBITDA528M-10.83M-4,874%
Gain YTD-5.309-16.64132%
P/E Ratio577.05N/A-
Revenue4.03B196M2,056%
Total Cash183M262M70%
Total Debt2.79B23.7M11,755%
FUNDAMENTALS RATINGS
CRL: Fundamental Ratings
CRL
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRLCTKB
RSI
ODDS (%)
Bearish Trend 7 days ago
62%
Bearish Trend 7 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 7 days ago
83%
Momentum
ODDS (%)
Bullish Trend 7 days ago
65%
Bullish Trend 7 days ago
83%
MACD
ODDS (%)
Bullish Trend 7 days ago
65%
Bullish Trend 7 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
69%
Bullish Trend 7 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
73%
Bullish Trend 7 days ago
77%
Advances
ODDS (%)
Bullish Trend 9 days ago
70%
Bullish Trend 23 days ago
76%
Declines
ODDS (%)
Bearish Trend 16 days ago
69%
Bearish Trend 9 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
76%
Bearish Trend 7 days ago
81%
Aroon
ODDS (%)
Bearish Trend 7 days ago
75%
Bullish Trend 7 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
CRL
Daily Signal:
Gain/Loss:
CTKB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HRIIX16.18N/A
N/A
Hood River International Opportunity Inv
CIQRX14.06N/A
N/A
Segall Bryant & Hamll Intl Eq Retl
CGFYX90.78N/A
N/A
Columbia Cornerstone Growth Inst 3
MSCGX11.88N/A
N/A
Mercer US Small/Mid Cap Equity Y3
GMAYX23.62N/A
N/A
GMO Small Cap Quality I

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
-0.73%
IQV - CRL
73%
Closely correlated
-1.23%
A - CRL
65%
Loosely correlated
-0.85%
RVTY - CRL
65%
Loosely correlated
+0.33%
MTD - CRL
63%
Loosely correlated
-1.48%
DHR - CRL
58%
Loosely correlated
+1.11%
More

CTKB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTKB has been loosely correlated with BRKR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CTKB jumps, then BRKR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTKB
1D Price
Change %
CTKB100%
+1.50%
BRKR - CTKB
47%
Loosely correlated
-1.21%
CRL - CTKB
44%
Loosely correlated
-0.73%
RVTY - CTKB
42%
Loosely correlated
+0.33%
LAB - CTKB
40%
Loosely correlated
N/A
A - CTKB
39%
Loosely correlated
-0.85%
More